Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Scalable and ultrafast CAR-T cell production using microfluidics

1 Jan 2025

Abstract excerpt

4.18 ± 1.69%, respectively, in the final CAR-T product. Our results highlight MFDs as a scalable platform to streamline CAR-T manufacturing, with the potential to improve clinical accessibility and outcomes by reducing the production time while preserving essential T-cell phenotypes.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Viral Infectious Diseases and Gene Expression in Insects
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40396473
DOI: 10.1039/d5lc00139k

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Scalable and ultrafast CAR-T cell production using microfluidicsPMID 40396473Read ↗

High-density microbioreactor process designed for automated point-of-care manufacturing of CAR T cellsSemantic proximity Read ↗

Cell trajectory modulation: rapid microfluidic biophysical profiling of CAR T cell functional phenotypesSemantic proximity Read ↗

Revolutionizing CAR T Cell Therapies: Innovations in Genetic Engineering and Manufacturing to Enhance Efficacy and AccessibilitySemantic proximity Read ↗

Development of a microfluidic cell transfection device into gene-edited CAR T cell manufacturing workflowSemantic proximity Read ↗

Automated, scaled, transposon-based production of CAR T cellsSemantic proximity Read ↗

Scaling up and scaling out: Advances and challenges in manufacturing engineered T cell therapiesSemantic proximity Read ↗

An open CAR-T single-cell atlas to enable in-depth characterization and rational engineering of CAR-T productsSemantic proximity Read ↗

Microfluidic T-Chip enables one-step clinical-scale T-cell purification from blood products for CAR T-cell manufacturingSemantic proximity Read ↗

Deterministic Lateral Displacement: The Next-Generation CAR T-Cell Processing?Semantic proximity Read ↗

Droplet microfluidics forward for tracing target cells at single-cell transcriptome resolutionSemantic proximity Read ↗

Programmable microparticles rewire CAR signaling to enable super-physiological expansion of human T cells <i>in vitro</i>Semantic proximity Read ↗

Titering of Chimeric Antigen Receptors on CAR T Cells enabled by a Microfluidic-based Dosage-Controlled Intracellular mRNA Delivery PlatformSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.